Literature DB >> 23088335

Enumeration of 166 billion organic small molecules in the chemical universe database GDB-17.

Lars Ruddigkeit1, Ruud van Deursen, Lorenz C Blum, Jean-Louis Reymond.   

Abstract

Drug molecules consist of a few tens of atoms connected by covalent bonds. How many such molecules are possible in total and what is their structure? This question is of pressing interest in medicinal chemistry to help solve the problems of drug potency, selectivity, and toxicity and reduce attrition rates by pointing to new molecular series. To better define the unknown chemical space, we have enumerated 166.4 billion molecules of up to 17 atoms of C, N, O, S, and halogens forming the chemical universe database GDB-17, covering a size range containing many drugs and typical for lead compounds. GDB-17 contains millions of isomers of known drugs, including analogs with high shape similarity to the parent drug. Compared to known molecules in PubChem, GDB-17 molecules are much richer in nonaromatic heterocycles, quaternary centers, and stereoisomers, densely populate the third dimension in shape space, and represent many more scaffold types.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23088335     DOI: 10.1021/ci300415d

Source DB:  PubMed          Journal:  J Chem Inf Model        ISSN: 1549-9596            Impact factor:   4.956


  130 in total

1.  Mappability of drug-like space: towards a polypharmacologically competent map of drug-relevant compounds.

Authors:  Pavel Sidorov; Helena Gaspar; Gilles Marcou; Alexandre Varnek; Dragos Horvath
Journal:  J Comput Aided Mol Des       Date:  2015-11-12       Impact factor: 3.686

2.  Estimation of the size of drug-like chemical space based on GDB-17 data.

Authors:  P G Polishchuk; T I Madzhidov; A Varnek
Journal:  J Comput Aided Mol Des       Date:  2013-08-21       Impact factor: 3.686

3.  ISiCLE: A Quantum Chemistry Pipeline for Establishing in Silico Collision Cross Section Libraries.

Authors:  Sean M Colby; Dennis G Thomas; Jamie R Nuñez; Douglas J Baxter; Kurt R Glaesemann; Joseph M Brown; Meg A Pirrung; Niranjan Govind; Justin G Teeguarden; Thomas O Metz; Ryan S Renslow
Journal:  Anal Chem       Date:  2019-03-06       Impact factor: 6.986

Review 4.  Generative chemistry: drug discovery with deep learning generative models.

Authors:  Yuemin Bian; Xiang-Qun Xie
Journal:  J Mol Model       Date:  2021-02-04       Impact factor: 1.810

Review 5.  Twenty years on: the impact of fragments on drug discovery.

Authors:  Daniel A Erlanson; Stephen W Fesik; Roderick E Hubbard; Wolfgang Jahnke; Harren Jhoti
Journal:  Nat Rev Drug Discov       Date:  2016-07-15       Impact factor: 84.694

6.  Ring system-based chemical graph generation for de novo molecular design.

Authors:  Tomoyuki Miyao; Hiromasa Kaneko; Kimito Funatsu
Journal:  J Comput Aided Mol Des       Date:  2016-06-14       Impact factor: 3.686

7.  Congestion game scheduling for virtual drug screening optimization.

Authors:  Natalia Nikitina; Evgeny Ivashko; Andrei Tchernykh
Journal:  J Comput Aided Mol Des       Date:  2017-12-20       Impact factor: 3.686

8.  Molpher: a software framework for systematic chemical space exploration.

Authors:  David Hoksza; Petr Skoda; Milan Voršilák; Daniel Svozil
Journal:  J Cheminform       Date:  2014-03-21       Impact factor: 5.514

Review 9.  Getting the most out of PubChem for virtual screening.

Authors:  Sunghwan Kim
Journal:  Expert Opin Drug Discov       Date:  2016-08-05       Impact factor: 6.098

Review 10.  Discovery of potent positive allosteric modulators of the α3β2 nicotinic acetylcholine receptor by a chemical space walk in ChEMBL.

Authors:  Justus J Bürgi; Mahendra Awale; Silvan D Boss; Tifany Schaer; Fabrice Marger; Juan M Viveros-Paredes; Sonia Bertrand; Jürg Gertsch; Daniel Bertrand; Jean-Louis Reymond
Journal:  ACS Chem Neurosci       Date:  2014-03-04       Impact factor: 4.418

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.